BACKGROUND: Patients with schizophrenia display metacognitive impairments, such as hasty decision-making during probabilistic reasoning - the "jumping to conclusion" bias (JTC). Our recent fMRI study revealed reduced activations in the right ventral striatum (VS) and the ventral tegmental area (VTA) to be associated with decision-making in patients with schizophrenia. It is unclear whether these functional alterations occur in the at-risk mental state (ARMS). METHODS: We administered the classical beads task and fMRI among ARMS patients and healthy controls matched for age, sex, education and premorbid verbal intelligence. None of the ARMS patients was treated with antipsychotics. Both tasks request probabilistic decisions after a variable amount of stimuli. We evaluated activation during decision-making under certainty versus uncertainty and the process of final decision-making. RESULTS: We included 24 AMRS patients and 24 controls in our study. Compared with controls, ARMS patients tended to draw fewer beads and showed significantly more JTC bias in the classical beads task, mirroring findings in patients with schizophrenia. During fMRI, ARMS patients did not demonstrate JTC bias on the behavioural level, but showed a significant hypoactivation in the right VS during the decision stage. LIMITATIONS: Owing to the cross-sectional design of the study, results are constrained to a better insight into the neurobiology of risk constellations, but not prepsychotic stages. Nine of the ARMS patients were treated with antidepressants and/or lorazepam. CONCLUSION: As in patients with schizophrenia, a striatal hypoactivation was found in ARMS patients. Confounding effects of antipsychotic medication can be excluded. Our findings indicate that error prediction signalling and reward anticipation may be linked to striatal dysfunction during prodromal stages and should be examined for their utility in predicting transition risk.
BACKGROUND:Patients with schizophrenia display metacognitive impairments, such as hasty decision-making during probabilistic reasoning - the "jumping to conclusion" bias (JTC). Our recent fMRI study revealed reduced activations in the right ventral striatum (VS) and the ventral tegmental area (VTA) to be associated with decision-making in patients with schizophrenia. It is unclear whether these functional alterations occur in the at-risk mental state (ARMS). METHODS: We administered the classical beads task and fMRI among ARMS patients and healthy controls matched for age, sex, education and premorbid verbal intelligence. None of the ARMS patients was treated with antipsychotics. Both tasks request probabilistic decisions after a variable amount of stimuli. We evaluated activation during decision-making under certainty versus uncertainty and the process of final decision-making. RESULTS: We included 24 AMRSpatients and 24 controls in our study. Compared with controls, ARMS patients tended to draw fewer beads and showed significantly more JTC bias in the classical beads task, mirroring findings in patients with schizophrenia. During fMRI, ARMS patients did not demonstrate JTC bias on the behavioural level, but showed a significant hypoactivation in the right VS during the decision stage. LIMITATIONS: Owing to the cross-sectional design of the study, results are constrained to a better insight into the neurobiology of risk constellations, but not prepsychotic stages. Nine of the ARMS patients were treated with antidepressants and/or lorazepam. CONCLUSION: As in patients with schizophrenia, a striatal hypoactivation was found in ARMS patients. Confounding effects of antipsychotic medication can be excluded. Our findings indicate that error prediction signalling and reward anticipation may be linked to striatal dysfunction during prodromal stages and should be examined for their utility in predicting transition risk.
Authors: Nigel Blackwood; Dominic Ffytche; Andrew Simmons; Richard Bentall; Robin Murray; Robert Howard Journal: Brain Res Cogn Brain Res Date: 2004-06
Authors: Zachary B Millman; Keith Gallagher; Caroline Demro; Jason Schiffman; Gloria M Reeves; James M Gold; Pamela J Rakhshan Rouhakhtar; John Fitzgerald; Nicole D Andorko; Samantha Redman; Robert W Buchanan; Laura M Rowland; James A Waltz Journal: Schizophr Res Date: 2019-04-15 Impact factor: 4.939
Authors: Stephanie N L Schmidt; Sabrina C Fenske; Peter Kirsch; Daniela Mier Journal: Eur Arch Psychiatry Clin Neurosci Date: 2018-10-25 Impact factor: 5.270
Authors: Pan Lin; Xiaosheng Wang; Bei Zhang; Brian Kirkpatrick; Dost Öngür; James J Levitt; Jorge Jovicich; Shuqiao Yao; Xiang Wang Journal: Hum Brain Mapp Date: 2017-11-02 Impact factor: 5.038
Authors: Gregory P Strauss; Raktima Datta; William Armstrong; Ian M Raugh; Nina V Kraguljac; Adrienne C Lahti Journal: Eur Neuropsychopharmacol Date: 2021-04-02 Impact factor: 5.415